Treatment of so-called idiopathic follicular mucinosis with hydroxychloroquine

Br J Dermatol. 2010 Aug;163(2):420-3. doi: 10.1111/j.1365-2133.2010.09759.x. Epub 2010 Mar 10.

Abstract

There exists no treatment of choice for follicular mucinosis (FM). Historically two distinct entities of FM have been proposed: FM of children and young adults not associated with other diseases ('idiopathic' FM), and FM in elderly patients associated with mycosis fungoides and Sézary syndrome ('lymphoma-associated' FM). Nowadays it is suggested that 'idiopathic' FM might represent a localized form of cutaneous T-cell lymphoma. Six patients with 'idiopathic' FM were treated with hydroxychloroquine (HCQ) at a dose of 200 mg three times daily for 10 days followed by a dose adjusted to the ideal body weight, usually 200 mg twice daily. All patients showed an improvement of 'idiopathic' FM already after 6 weeks and a complete remission with full hair regrowth after 2-5 months of HCQ therapy. In all patients no relapse occurred during follow up of between 3 and 23 years and no patient developed lymphoma. We conclude that HCQ is a highly effective therapy without significant side-effects in the treatment of so-called 'idiopathic' FM.

Publication types

  • Case Reports

MeSH terms

  • Abdomen / diagnostic imaging
  • Aged
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Gene Rearrangement
  • Genes, T-Cell Receptor gamma / genetics
  • Hair / drug effects
  • Hair / growth & development
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • Lymph Nodes / diagnostic imaging
  • Male
  • Middle Aged
  • Mucinosis, Follicular / drug therapy*
  • Mucinosis, Follicular / genetics
  • Mucinosis, Follicular / pathology
  • Treatment Outcome
  • Ultrasonography

Substances

  • Enzyme Inhibitors
  • Hydroxychloroquine